On CNBC’s ‘Halftime Report Final Trades,’ a panel of experts shared their final trading picks, offering insights into the market’s current sentiment. Stephen Weiss of Short Hills Capital Partners expressed his continued confidence in Taiwan Semiconductor Manufacturing Company Limited (TSM), believing it remains undervalued. This sentiment is bolstered by the recent government approval for an additional $7.5 billion investment into Taiwan Semiconductor’s Arizona unit, as reported by the Taipei Times.
Amy Raskin of Chevy Chase Trust highlighted Regeneron Pharmaceuticals, Inc. (REGN) as her pick. While Regeneron faced a setback in its attempt to block the sale of Amgen Inc’s (AMGN) Eylea biosimilar, the company has since filed an appeal to the U.S. Court of Appeals for the Federal Circuit. This suggests Regeneron remains committed to defending its market share in the biosimilar space.
Kari Firestone of Aureus Asset Management opted for American Tower Corporation (AMT) as her final trade. This choice is supported by JP Morgan analyst Philip Cusick, who maintained an Overweight rating and raised the price target from $240 to $250. Cusick’s positive outlook reflects the continued growth potential in the tower infrastructure sector.
Joseph M. Terranova of Virtus Investment Partners selected Trane Technologies plc (TT) for its strong performance. Trane Technologies recently delivered better-than-expected second-quarter financial results and raised its FY24 guidance. The company’s revenues grew 13% year-over-year to $5.31 billion, surpassing analyst expectations, with bookings increasing 19% to $5.34 billion. Trane Technologies’ strong financial performance and positive outlook make it an attractive investment opportunity.
These analysts’ picks offer valuable perspectives on the current market and highlight the opportunities available in various sectors. Investors can use this information to make informed decisions and capitalize on potential market trends.
